Market Analysis on Patient Safety Conference

This report estimates that the assorted adverse events place an extra price burden of $317.9 billion on hospitals across the United States of America and Western Europe, adversely poignant 91.08 million patients and resulting in 01.95 million deaths in 2016. The price burden is predicted to extend at a CAGR of 03.02% to achieve $383.7 billion by 2022.